Health records operation looking to raise $20M
The Indiana Health Information Exchange Inc. hopes to raise roughly $20 million over three years to take its health information technology services to hospitals around the country.
Health Care & Life Sciences
Articles
Deal raises hopes for Healthy Indiana Plan expansion
Gov. Mike Pence’s strategy for expanding Medicaid in Indiana is to convince or cajole the Obama administration to let him use the Healthy Indiana Plan to do it. A recent deal in Arkansas seems to make it more likely that the Obama team will give Pence what he wants.
Bonuses drive up compensation for Lilly’s top brass
Eli Lilly and Co. granted larger bonuses to its top five executives early this year, which boosted their 2012 compensation anywhere from 3 percent to 8 percent.
Court may decide if drugmakers can pay to delay generics
Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines.
Company taps sports market with bacteria-stalking chemical
Anderson-based Coeus Technology has invented a chemical that kills dangerous bacteria, including potentially deadly staph, by forming a germ-killing barrier that lasts two weeks to six months.
Healthy Indiana Plan gets mixed reviews at hearing
Hospital officials praised Indiana's medical savings accounts but some consumer advocates panned them Wednesday during a public hearing as Gov. Mike Pence seeks federal approval to use the Healthy Indiana Plan to expand Medicaid in this state.
Studies: Employers could save with Medicaid expansion
The debate over expanding Medicaid in Indiana so far has hinged on how much it will cost. But two recent studies suggest Hoosier employers should be focused on how much a Medicaid expansion will save them: perhaps as much as $400 million per year.
Profits at center of biosimilars debate
House Bill 1315, which is scheduled for a Senate floor hearing on Monday, would require pharmacists to check with a patient’s physician before automatically substituting a generic version of a biotech drug for a brand-name version.
Panel advances tougher synthetic drugs bill
Indiana lawmakers are advancing a bill that would make it illegal to possess or deal "lookalike" synthetic drugs similar to those known as "bath salts" and other nicknames.
Feds delay decision on Indiana Medicaid plan
The federal government has delayed action on Indiana's proposal to expand Medicaid because the state hasn't received public comment on the proposals, but the issue could be resolved quickly with two hearings set for next week, a spokeswoman for Gov. Mike Pence said Wednesday.
Indiana crop insurance payouts for 2012 losses top $1B
Purdue University said Tuesday that Indiana farmers received payouts for 2012 corn, soybean and wheat losses that are nearly twice as much as the previous record of $522 million in 2008.
Medical device maker moving to Noblesville, adding jobs
Fishers-based Nexxt Spine LLC, a manufacturer of spinal implants, is consolidating operations and moving its headquarters and manufacturing facility to Noblesville.
Drugmakers, Interpol ramp up fight against fakes
More than two dozen of the world's largest pharmaceutical companies, including Indianapolis-based Eli Lilly and Co., have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs.
Q&A
Mike Sherman, the chief financial officer at West Lafayette-based Endocyte Inc., talked about how the drug firm’s funding partnership with New Jersey-based Merck & Co. Inc. has helped accelerate development of the company’s pipeline, which is branching out into drugs to treat cancers of the lung, prostate and breast.
Analysis: Feds likely to cut Medicaid support
A fellow conservative provided some support for Gov. Mike Pence’s claim that an expansion of Medicaid will become a “baby elephant” that eats up larger and larger shares of state resources.
Study: Inpatient declines to hit all hospitals
One explanation for Indiana University Health’s decision to delay its Methodist Hospital expansion is that new “value-based” payment models appear to be pushing down hospitalization rates, according to a study released Friday.
IU Health puts Methodist expansion plans on hold
Citing concerns about the economy and federal health reform, Indiana University Health has pressed pause on its plans to build a bed tower at Methodist Hospital that could have cost it as much as $500 million.
Overseas tax savings for U.S. drugmakers under threat
Eli Lilly and Co. and five other big drugmakers avoided paying $7 billion in U.S. taxes last year by shifting their profits overseas. The strategy has drawn the ire of some legislators.
Damages awarded in J&J’s DePuy hip implant case
Warsaw-based DePuy was accused of knowingly marketing a faulty implant that was later recalled.
Lawmakers struggle with bill to stop synthetic drug sales
Lawmakers are finding it difficult to write a law that effectively cracks down on the sale of synthetic drugs while remaining fair to businesses that might not know they’re on their shelves.